Sort   by:  
 Page size 
ProteomicsPlasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and is a prognostic biomarker for severe COVID-19
The disease caused by the novel coronavirus of 2019 (COVID-19) has resulted in significant morbidity and mortality world-wide. A systemic hyper-inflammation characterizes the severe COVID-19 disease often associated with acute respiratory distress syndrome (ARDS). Bloodbiomarkers with prognostic rel...
ORGANISM(S): Homo sapiens (Human) 
2023-07-17 | PXD026510 | Pride
Ards Soluble upar Plaur Myeloid cells Covid-19 Prognosis 
ProteomicsClinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
A randomised control trial was done to assess clinical and immunological benefits of passive immunization using convalescent plasma therapy (CPT), compared with standard of care, in severe COVID-19 patients presenting with acute respiratory distress syndrome (ARDS). Plasma abundance of a large panel...
ORGANISM(S): Homo sapiens (Human) 
2022-02-17 | PXD025453 | Pride
Covid-19 Ards Convalescent plasma therapy (cpt) Acute respiratory distress syndrome (ards) Sawth-ms 
UnknownAssociation of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.
Not available
S-EPMC10170741 | biostudies-literature
UnknownKLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes.
Not available
S-EPMC5681279 | biostudies-literature
UnknownA phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Not available
S-EPMC8770561 | biostudies-literature
Sort   by:  
 Page size